(Q42496765)

1 November 2017

title

Expression of plasminogen activator inhibitor type 2 in normal and psoriatic epidermis (English)

1 reference

1 November 2017

1 reference

B Lyons-Giordano

1

1 reference

1 November 2017

D Loskutoff

2

1 reference

1 November 2017

C S Chen

3

1 reference

1 November 2017

G Lazarus

4

1 reference

1 November 2017

M Keeton

5

1 reference

1 November 2017

P J Jensen

6

1 reference

1 November 2017

language of work or name

1 reference

1 February 1994

1 reference

1 November 2017

1 reference

1 November 2017

volume

101

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

105-112

1 reference

Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells

1 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00269356

The serpin-enzyme complex (SEC) receptor mediates the neutrophil chemotactic effect of alpha-1 antitrypsin-elastase complexes and amyloid-beta peptide

21 January 2018

1 reference

12 December 2020

Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue

1 reference

12 December 2020

Differentiation-linked expression of the plasminogen activator inhibitor type-2 gene in the human HL-60 promyelocytic cell line

1 reference

12 December 2020

Differential protease expression by cutaneous squamous and basal cell carcinomas

1 reference

12 December 2020

Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators

1 reference

12 December 2020

Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme

1 reference

12 December 2020

The plasminogen activator/plasmin system

1 reference

12 December 2020

Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells

1 reference

12 December 2020

The ovalbumin family of serpin proteins

1 reference

12 December 2020

mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis

1 reference

12 December 2020

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

1 reference

12 December 2020

Evidence for an Alternative Pathway of Keratinocyte Maturation in Psoriasis from an Antigen Found in Psoriatic but Not Normal Epidermis

1 reference

12 December 2020

Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2.

1 reference

12 December 2020

Changes in keratinocyte maturation during wound healing

1 reference

12 December 2020

Plasminogen activator inhibitor 1, the primary regulator of fibrinolysis, in normal human cerebrospinal fluid.

1 reference

12 December 2020

Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placenta

1 reference

12 December 2020

Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937

1 reference

12 December 2020

Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells

1 reference

12 December 2020

Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor

1 reference

12 December 2020

Plasminogen activator inhibitors: hormonally regulated serpins

1 reference

12 December 2020

Plasminogen activator in psoriatic scales is of the tissue-type PA as identified by monoclonal antibodies

1 reference

12 December 2020

Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds

1 reference

12 December 2020

Plasminogen activator-specific inhibitors produced by human monocytes/macrophages

1 reference

12 December 2020

Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells

1 reference

12 December 2020

Inhibitors and proactivators of fibrinolysis in human epidermis

1 reference

12 December 2020

Epidermal plasminogen activator is abnormal in cutaneous lesions

1 reference

12 December 2020

Inhibition of human neutrophil superoxide generation by alpha 1-antichymotrypsin

1 reference

12 December 2020

Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants

1 reference

12 December 2020

Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma

1 reference

12 December 2020

Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation

1 reference

12 December 2020

Hair follicle stem cells: their location, role in hair cycle, and involvement in skin tumor formation

1 reference

12 December 2020

Human skin proteases. Differential extraction of proteases and of endogenous protease inhibitors

1 reference

12 December 2020

Plasminogen activator inhibitors

1 reference

12 December 2020

Epidermal plasminogen activator inhibitor (PAI) is immunologically identical to placental-type PAI-2

1 reference

12 December 2020

Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor

1 reference

12 December 2020

Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue

1 reference

12 December 2020

Detection and partial characterization of an inhibitor of plasminogen activator in human platelets

1 reference

12 December 2020

Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells

1 reference

12 December 2020

Plasminogen activator inhibitor (type-1) in rat adrenal medulla

1 reference

12 December 2020

Epidermal differentiation: the bare essentials

1 reference

12 December 2020

Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins

1 reference

12 December 2020

Cellular localisation in placenta of placental type plasminogen activator inhibitor

1 reference

12 December 2020

Tissue plasminogen activator

1 reference

12 December 2020

Plasminogen is present in the basal layer of the epidermis

1 reference

12 December 2020

An inhibitor of plasminogen activation from human placenta. Purification and characterization

1 reference

12 December 2020

Plasminogen activators, tissue degradation, and cancer

1 reference

12 December 2020

Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin

1 reference

12 December 2020

Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene

1 reference

12 December 2020

Regulation of plasminogen activator inhibitor mRNA levels in lipopolysaccharide-stimulated human monocytes. Correlation with production of the protein

1 reference

12 December 2020

Directed plasminogen activation at the surface of normal and malignant cells

1 reference

12 December 2020

Tissue plasminogen activator inhibitor in the epidermis

1 reference

12 December 2020

Fibrinolytic pathways and the endothelium

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00269356

1 reference

1 November 2017

1 reference